Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for GI Toxicity in Pediatric ALL
NCT06560879Phase 2Enrolling by invitation
- Sponsor
- National Institute of Pediatrics
- Start
- Feb 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (4 arms), sponsored by National Institute of Pediatrics. Primary endpoints: Prevention of Mucositis at 8 weeks, Prevention of Diarrhea at 8 weeks and 5 more. Started Feb 2025; status: enrolling by invitation.
Beyond the preview
Go deeper on NCT06560879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06560879.